The 252A/G and 804C/A polymorphisms of Lymphotoxin-alpha is associated to onset of acute myocardial infarction in Taiwan

Laboratory Medicine

Volumn 41, Issue 4, 2010, Pages 220-225

  Wang, Yi Cheng ^a   Chen, Chun Chang ^a   Zhang, Wei Duo ^a   Zhang, Shi Kun ^a   Chang, Fu Hsin ^b,c   Hsu, Li Sung ^d,e  

^a KAOHSIUNG ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^b Asia Pacific Biotech Developing ^*  (Taiwan)

^c NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^e CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Acute myocardial infarction; Disease risk; Galectin 2; Gene polymorphisms; Lymphotoxin alpha

Indexed keywords

LYMPHOTOXIN;

ACUTE HEART INFARCTION; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DNA POLYMORPHISM; DNA SEQUENCE; GENE; GENE FREQUENCY; GENETIC RISK; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HOMOZYGOSITY; HUMAN; LGALS2 GENE; MAJOR CLINICAL STUDY; POPULATION BASED CASE CONTROL STUDY; PREVALENCE; RISK ASSESSMENT; TAIWAN;

EID: 77951962240     PISSN: 00075027     EISSN: None     Source Type: Journal    
DOI: 10.1309/LM6NPRVF05SJBAVQ     Document Type: Article

References (24)

1. Wang YC, Hwang JJ, Hung CS, et al. Outcome of primary percutaneous coronary intervention in octogenarians with acute myocardial infarction. J Formos Med Assoc. 2006;105:451-458.
2. Liu PY, Chen JH, Li YH, et al. Synergistic effect of stromelysin-1 (matrix metallo-proteinase-3) promoter 5A/6A polymorphism with smoking on the onset of young acute myocardial infarction. Thromb Haemost. 2003;90:132-139.
3. Glass CK, Witztum JL. Atherosclerosis. The road ahead. Cell. 2001;104:503-516.
4. Puddu P, Cravero E, Puddu GM, et al. Genes and atherosclerosis: At the origin of the predisposition. Int J Clin Pract. 2005;59:462-472.
5. Lee SH, Lee TW, Ihm CG, et al. Genetics of diabetic nephropathy in type 2 DM: Candidate gene analysis for the pathogenic role of inflammation. Nephrology (Carlton). 2005;10:S32-S36.
6. Incalcaterra E, Hoffmann E, Averna MR, et al. Genetic risk factors in myocardial infarction at young age. Minerva Cardioangiol. 2004;52:287-312. (Pubitemid 39312180)
7. Wang Q. Advances in the genetic basis of coronary artery disease. Curr Atheroscler Rep. 2005;7:235-241. (Pubitemid 40796757)
8. Harrap SB, Zammit KS, Wong ZY, et al. Genome-wide linkage analysis of the acute coronary syndrome suggests a locus on chromosome 2. Arterioscler Thromb Vasc Biol. 2002;22:874-878.
9. Hengstenberg C, Brockel U, Holmer S, et al. Genetic factors in myocardial infarction - Results from a candidate gene and a genome-wide approach between beta blockers. Herz. 2002;27:649-661.
10. Ozaki K, Inoue K, Sato H, et al. Functional variation in LGALS2 confers risk of myocardial infarction and regulates lymphotoxin-alpha secretion in vitro. Nature. 2004;429:72-75.
11. Iida A, Ozaki K, Ohnishi Y, et al. Identification of 46 novel SNPs in the 130-kb region containing a myocardial infarction susceptibility gene on chromosomal band 6p21. J Hum Genet. 2003;48:476-479.
12. Mizuno H, Sato H, Sakata Y, et al. Impact of atherosclerosis-related gene polymorphisms on mortality and recurrent events after myocardial infarction. Atherosclerosis. 2006;185:400-405. (Pubitemid 43306756)
13. Ozaki K, Ohnishi Y, Iida A, et al. Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction. Nat Genet. 2002;32:650-654. (Pubitemid 35435179)
14. Asselbergs FW, Pai JK, Rexrode KM, et al. Effects of lymphotoxin-alpha gene and galectin-2 gene polymorphisms on inflammatory biomarkers, cellular adhesion molecules and risk of coronary heart disease. Clin Sci (Lond). 2007;112:291-298.
15. Clarke R, Xu P, Bennett D, et al. Lymphotoxin-alpha gene and risk of myocardial infarction in 6,928 cases and 2,712 controls in the ISIS casecontrol study. PLoS Genet. 2006;2:e107. (Pubitemid 44147403)
16. Yamada A, Ichihara S, Murase Y, et al. Lack of association of polymorphisms of the lymphotoxin alpha gene with myocardial infarction in Japanese. J Mol Med. 2004;82:477-483. (Pubitemid 39044287)
17. Auer J, Weber T, Berent R, et al. Genetic polymorphisms in cytokine and adhesion molecule genes in coronary artery disease. Am J Pharmacogenomics. 2003;3:317-328.
18. Kempf K, Haltern G, Futh R, et al. Increased TNF-alpha and decreased TGF-beta expression in peripheral blood leukocytes after acute myocardial infarction. Horm Metab Res. 2006;38:346-351.
19. Naoum JJ, Chai H, Lin PH, et al. Lymphotoxin-alpha and cardiovascular disease: Clinical association and pathogenic mechanisms. Med Sci Monit. 2006;12:RA121-RA124.
20. Schreyer SA, Vick CM, LeBoeuf RC. Loss of lymphotoxin-alpha but not tumor necrosis factor-alpha reduces atherosclerosis in mice. J Biol Chem. 2002;277:12364-12368.
21. Suzuki G, Izumi S, Hakoda M, et al. LTA 252G allele containing haplotype block is associated with high serum C-reactive protein levels. Atherosclerosis. 2004;176:91-94.
22. Ozaki K, Tanaka T. Genome-wide association study to identify SNPs conferring risk of myocardial infarction and their functional analyses. Cell Mol Life Sci. 2005;62:1804-1813.
23. Christensen MB, Lawlor DA, Gaunt TR, et al. Genotype of galectin 2 (LGALS2) is associated with insulin-glucose profile in the British Women's Heart and Health Study. Diabetologia. 2006;49:673-677.
24. Mangino M, Braund P, Singh R, et al. LGALS2 functional variant rs7291467 is not associated with susceptibility to myocardial infarction in Caucasians. Atherosclerosis. 2007;194:112-115.